Tim Wright, Editor, Contract Pharma06.17.21
Prior to 2020, historically low-cost manufacturing, with just-in-time production and logistics, was key to staying competitive. In a time of crisis, however, the consequences of this model have become all too apparent. The leadership team at Dr. Reddy's rose to the challenge by adapting quickly, decisively and without hesitation. Identifying opportunities for improvement in supply and building new digital infrastructure helped the company deliver on their promises to customers and established a framework for the new normal. Vin Colicchio discusses the challenges and solutions of maintaining drug supply during the COVID crisis, and how the pandemic has changed the company's business model.
Contract Pharma: How has Dr. Reddy’s coped with supply chain interference from the pandemic?
Vincent Colicchio: Dr. Reddy’s approached the pandemic with the same patient-centric philosophy to continue supplying products as quickly as possible to avoid any supply gaps. We focused on our two priorities to help communities in India and around the world:
&nbs
Contract Pharma: How has Dr. Reddy’s coped with supply chain interference from the pandemic?
Vincent Colicchio: Dr. Reddy’s approached the pandemic with the same patient-centric philosophy to continue supplying products as quickly as possible to avoid any supply gaps. We focused on our two priorities to help communities in India and around the world:
&nbs
Continue reading this story and get 24/7 access to Contract Pharma for FREE
FREE SUBSCRIPTION
